A Glasgow-based drug development company has been acquired by a market leader in its field.
SB Drug Discovery, which specialises in ion channel and receptor drug discovery research, has been purchased by Nottingham-based Sygnature Discovery.
The acquisition will see both companies continue to operate out of their respective facilities, with further investment and service expansion planned by SG in the coming months.
